DigitalDrifter
Senior Member (Voting Rights)
Where did you get that figure from?At least 1 in 200 people have ME
Where did you get that figure from?At least 1 in 200 people have ME
I admittedly didn't do much digging to verify it, but this video posted by World ME Alliance a few days ago which says there are an estimated 55 million pwME:Where did you get that figure from?
I can't say that it wasn't just masking, but it seems unlikely. I had those temporary remissions from at least 3 different chemicals (prednisone, cuminaldehyde, and T2 (3-5 diiodothyronine). I think it's extremely unlikely that those three chemicals could have exactly the same masking effect. It seems more likely that they're switching something off in ME's mechanism. If ME is a feedback loop with multiple factors, these chemicals could affect the loop the same way by adjusting different factors.Can you be sure the symptoms weren't just temporarily masked?
I can't say that it wasn't just masking, but it seems unlikely. I had those temporary remissions from at least 3 different chemicals (prednisone, cuminaldehyde, and T2 (3-5 diiodothyronine). I think it's extremely unlikely that those three chemicals could have exactly the same masking effect. It seems more likely that they're switching something off in ME's mechanism. If ME is a feedback loop with multiple factors, these chemicals could affect the loop the same way by adjusting different factors.
Ah, now I see that. It says "diagnosed rate" on the title and then "with diagnosis" on vertical axis. It's not the best graph I've seen.They say with a diagnosis i.e. prevalence of having a diagnosis, not time of being diagnosed.
True, gradual onsets would take more time to the diagnosis. But I thought that 30% was non-viral cases. From MEPedia.com: "85% of patients report a trigger. 72% of ME/CFS patients report that a bacterial or a viral infection was their onset of ME/CFS; 4.5% trauma; 4.5% surgery or childbirth; 2.2% allergic reaction; 1.7% stress or trauma."There is a significant percentage (over 30% I seem to remember)of Pwme with gradual onset. I’m one. I was diagnosed 8 years ago 7 years ago I saw a specialist who said I had had ME for 10-12 years.
So, it appears gradual onset is about 15%
@forestglip further thought - check out Gulf War Syndrome* - "weak form of the PON1 gene were nine times more likely to develop GWI. Normally the PON1 gene protects you from low-level nerve gas, but there is a strong form and a weak form of the gene."@forestglip I bring good news!---
Of course common variant genetic studies - GWAS [DecodeME] - is also a way to identify potential enviromental triggers --- genes which decrease/increase risk.
I'm hoping that DecodeME will provide clues and indeed metabolomics studies - Dr Li states that metabolite coverage is very low in ME/CFS - we haven't looked at most metabolites.
I'm hoping that this is an iterative process e.g. DecodeME finds genetic clues to focus research and metabolomics can therefore be more focused/targeted --- I'd settle for progress via other routes though!
Super interesting, thanks!check out Gulf War Syndrome* - "weak form of the PON1 gene were nine times more likely to develop GWI. Normally the PON1 gene protects you from low-level nerve gas, but there is a strong form and a weak form of the gene."
One of the things to keep in mind is that genetic study (GWAS) in Alzheimer's originally turned up a gene* which was difficult to interpret - it wasn't clear why the form of the gene related to risk. It is now assumed that gingivitis is the environmental factor i.e. explaining why the gene influences risk.Super interesting, thanks!
It is now assumed that gingivitis is the environmental factor
Basically the challenge AKA environmental(?) factor is your response to ongoing infection (gingivitis) but the pathogen isn't the discussion - more that you don't have to look for environmental factors -- just let the genes tell you what's going on.Environmental factor or comorbid conditions? --
Among the risk factors listed for gingivitis on CDC's website are smoking, poor nutrition, and "medication with oral side effects".
Ah, think I should have highlighted that genetics doesn't do "comorbid conditions" i.e. things you accidentally/incidentally have --- it just says what the actual problem is --- its advantage. Word of caution is that not every disease is genetic enough (for GWAS - DecodeME) to work --- results within 12 months!Environmental factor or comorbid conditions?
Ah, think I should have highlighted that genetics doesn't do "comorbid conditions" i.e. things you accidentally/incidentally have --- it just says what the actual problem is --- its advantage. Word of caution is that not every disease is genetic enough (for GWAS - DecodeME) to work --- results within 12 months!
Sure above is poorly worded!
My reply was wrong rather than "poorly worded"Environmental factor or comorbid conditions?
My reply was wrong rather than "poorly worded"
I think genetic studies get around "comorbid conditions" by selecting participants. Nath's [NIH] study [not a genetic study] also comes to mind - comments were made that he removed most people from the study i.e. due to comorbidities. DecodeME haven't released full exclusion criteria but I think they didn't e.g. accept people with thyroid problems (psychosis?).
In my earlier reply I was thinking of cause & consequence - GWAS aims to find the cause rather than the myriad of downstream consequences (disease) --- however, GWAS can help to point to environmental factors as per gingivitis/Alzheimer's.
Among other things - it took really big studies in Alzheimer's/dementia - like multiples of DecodeME.Yeah it'd be very cool if DecodeME gave us any clues like that!
Toxin and drug exposure
Some also hypothesise that toxin exposure could trigger ME/CFS (61), such as organophosphate compounds (152, 153) and heavy metals (154). In the early 1960s, researchers found that workers with chronic exposure to organophosphates, mainly in insecticides and after sheep dipping, experienced persistent central nervous system (CNS) changes (153). This included disabling fatigue exacerbated by exercise and associated with myalgia, excessive sleep, night sweats, irritable bowel syndrome (IBS) symptoms, and mental changes. It was hypothesised that the organophosphates induce various abnormalities such as an elevated prevalence of lymphoproliferative disorders associated with impaired natural killer (NK) cell and cytotoxic T cell function. Additionally, exposure to heavy metals, such as cadmium, may also contribute to the development of ME/CFS (154). Cadmium is a widespread environmental and occupational heavy metal pollutant and can potentially cause neurological symptoms. Cadmium induces neuronal death in cortical neurons through a combination of apoptosis and necrosis, involving reactive oxygen species (ROS) generation and lipid peroxidation (155). This action may explain decreased grey matter volume in ME/CFS (156), as well as certain effects on the CNS such as reduced attention levels and memory (157). Exposure to cadmium also potentially reduces cerebral blood flow (158) [particularly cortical blood flow (159)], as cadmium has a disruptive effect on angiogenesis (160). This reduced blood flow can result in neurological dysfunction and the abnormal neuroimaging observed in ME/CFS (158). Cadmium may accentuate inflammatory processes, which may in turn disrupt the HPA axis and trigger symptoms of ME/CFS (161, 162). However, the exact organ that cadmium toxicity targets is still unclear (154).
Furthermore, various drug exposure has been found to trigger symptoms that are typically present in ME/CFS (172). For example, widely prescribed fluoroquinolone antibiotics are usually prescribed to treat various infections such as pneumonia and sinusitis (173–175). However, these fluoroquinolones have been found to increase tendinopathy involving oxidative stress and mitochondrial toxicity (176–180). Hence, the use of such drugs may have a multisystem effect and lead to the development of chronic illnesses such as ME/CFS.
Should this paper not have its own thread?